Xenetic Biosciences, Inc. Forecast, price target & analysts
Xenetic Biosciences, Inc. Target price 2025 - Analyst rating & recommendation
Xenetic Biosciences, Inc. Classifications & Recommendation:
Xenetic Biosciences, Inc. Price Target
| Target Price | $40.80 |
| Price | $2.73 |
| Potential |
1,394.51%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Xenetic Biosciences, Inc. 2026 .
The average Xenetic Biosciences, Inc. target price is $40.80.
This is
1,394.51%
register free of charge
$42.00
1,438.46%
register free of charge
$40.40
1,379.85%
register free of charge
|
|
| A rating was issued by 6 analysts: 0 Analysts recommend Xenetic Biosciences, Inc. to buy, 3 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Xenetic Biosciences, Inc. stock has an average upside potential 2026 of
1,394.51%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 2.50 | 2.55 |
| 1.57% | 2.00% | |
| Net Margin | -158.40% | -125.66% |
| 2.58% | 20.67% |
3 Analysts have issued a sales forecast Xenetic Biosciences, Inc. 2025 . The average Xenetic Biosciences, Inc. sales estimate is
This results in the following potential growth metrics:
3 Xenetic Biosciences, Inc. Analysts have issued a net profit forecast 2025. The average Xenetic Biosciences, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.57 | -2.08 |
| 5.17% | 19.07% | |
| P/E | negative | |
| EV/Sales | 0.55 |
3 Analysts have issued a Xenetic Biosciences, Inc. forecast for earnings per share. The average Xenetic Biosciences, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Xenetic Biosciences, Inc....
Current Xenetic Biosciences, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 20 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 05 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 22 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 20 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 09 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 20 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 05 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 22 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 20 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
